Getagraph.com logo
S&P 500
(0.13%) 5 187.70 points
Dow Jones
(0.08%) 38 884 points
Nasdaq
(-0.10%) 16 333 points
Oil
(-0.40%) $78.07
Gas
(0.41%) $2.22
Gold
(-0.20%) $2 319.60
Silver
(-0.47%) $27.42
Platinum
(-0.08%) $987.60
USD/EUR
(0.14%) $0.931
USD/NOK
(0.37%) $10.94
USD/GBP
(0.14%) $0.801
USD/RUB
(0.00%) $91.44

Aktualne aktualizacje dla Sosei Group Corporation [4565.T]

Giełda: JPX Sektor: Healthcare Branża: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-08)

Expected move: +/- 0.00%

Ostatnio aktualizowano8 geg. 2024 @ 04:22
25% discount on Stockinvest.us - Use code: Podcast

1.84% ¥ 1 552.00

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 04:22):

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis...

Stats
Dzisiejszy wolumen 297 300
Średni wolumen 1.36M
Kapitalizacja rynkowa 138.82B
EPS ¥-2.13 ( 2024-02-13 )
Następna data zysków ( ¥35.75 ) 2024-05-08
Last Dividend ¥2.50 ( 2015-03-27 )
Next Dividend ¥0 ( N/A )
P/E -17.74
ATR14 ¥1.712 (0.11%)

Wolumen Korelacja

Długi: -0.09 (neutral)
Krótki: 0.62 (weak)
Signal:(62.673) Neutral

Sosei Group Corporation Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sosei Group Corporation Korelacja - Waluta/Towar

The country flag 0.80
( moderate )
The country flag 0.01
( neutral )
The country flag -0.78
( moderate negative )
The country flag 0.64
( weak )
The country flag 0.41
( neutral )
The country flag -0.85
( strong negative )

Sosei Group Corporation Finanse

Annual 2023
Przychody: ¥12.77B
Zysk brutto: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2023
Przychody: ¥12.77B
Zysk brutto: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2022
Przychody: ¥15.57B
Zysk brutto: ¥14.64B (94.05 %)
EPS: ¥4.67
FY 2021
Przychody: ¥17.71B
Zysk brutto: ¥16.78B (94.73 %)
EPS: ¥12.53

Financial Reports:

No articles found.

Sosei Group Corporation Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A)

Sosei Group Corporation Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend ¥2.50 2015-03-27
Last Dividend ¥2.50 2015-03-27
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out ¥2.50 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-05-08)
¥0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
4093.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3296.T Ex Dividend Junior 2023-12-28 Semi-Annually 0 0.00%
2374.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
9882.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8925.T No Dividend Player 2023-07-28 Sporadic 0 0.00%
8035.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7280.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
6523.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
5802.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4544.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.5631.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.04581.200-1.525-1.830[0 - 0.3]
returnOnEquityTTM-0.1171.500-2.41-3.62[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.790.80010.008.00[1 - 3]
quickRatioTTM3.570.80010.008.00[0.8 - 2.5]
cashRatioTTM2.861.50010.0010.00[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM-3.341.000-2.35-2.35[3 - 30]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 20]
debtEquityRatioTTM1.048-1.5005.81-8.71[0 - 2.5]
grossProfitMarginTTM0.6971.0001.7231.723[0.2 - 0.8]
operatingProfitMarginTTM-0.6921.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.07531.000-1.530-1.530[0.2 - 2]
assetTurnoverTTM0.08120.800-2.79-2.23[0.5 - 2]
Total Score-1.525

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-18.891.000-2.010[1 - 100]
returnOnEquityTTM-0.1172.50-1.551-3.62[0.1 - 1.5]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.3011.500-1.3260[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.4131.000-10.000[0.1 - 0.5]
Total Score-3.79

Sosei Group Corporation

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej